PHASE-II TRIAL OF COMBINED 5-FLUOROURACIL PLUS DOXORUBICIN PLUS CISPLATIN (FAP REGIMEN) IN ADVANCED GASTRIC-CARCINOMA

被引：0
|
作者：
ROUGIER, P
DROZ, JP
THEODORE, C
PIOT, G
HERAIT, P
RUFFIE, P
CARDE, P
CVITKOVIC, E
机构：
来源：
CANCER TREATMENT REPORTS | 1987年 / 71卷 / 12期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：1301 / 1302
页数：2
相关论文
共 50 条
  • [1] A PHASE-II TRIAL OF 5-FLUOROURACIL, DOXORUBICIN, MITOMYCIN-C, AND LEUCOVORIN IN ADVANCED GASTRIC-CARCINOMA
    ARBUCK, SG
    SILK, Y
    DOUGLASS, HO
    NAVA, H
    RUSTUM, YM
    MILLIRON, S
    CANCER, 1990, 65 (11) : 2442 - 2445
  • [2] PHASE-II TRIAL OF 5-FLUOROURACIL, ADRIAMYCIN AND CISPLATIN (FAP) IN ADVANCED GASTRIC-CANCER
    WAGENER, DJT
    YAP, SH
    WOBBES, T
    BURGHOUTS, JTM
    VANDAM, FE
    HILLEN, HFP
    HOOGENDOORN, GJ
    SCHEERDER, H
    VANDERVEGT, SGL
    CANCER CHEMOTHERAPY AND PHARMACOLOGY, 1985, 15 (01) : 86 - 87
  • [3] PHASE-II TRIAL OF 5-FLUOROURACIL PLUS MELPHALAN IN COLORECTAL CARCINOMA
    PRESANT, CA
    RATKIN, G
    KLAHR, C
    CANCER TREATMENT REPORTS, 1978, 62 (03): : 461 - 462
  • [4] 5-FLUOROURACIL VS EPIRUBICIN VS 5-FLUOROURACIL PLUS EPIRUBICIN IN ADVANCED GASTRIC-CARCINOMA
    LOEHRER, PJ
    HARRY, D
    CHLEBOWSKI, RT
    INVESTIGATIONAL NEW DRUGS, 1994, 12 (01) : 57 - 63
  • [5] NEOADJUVANT CHEMOTHERAPY IN LOCALLY ADVANCED GASTRIC-CARCINOMA - A PHASE-II TRIAL WITH COMBINED CONTINUOUS INTRAVENOUS 5-FLUOROURACIL AND BOLUS CISPLATINUM
    ROUGIER, P
    MAHJOUBI, M
    LASSER, P
    DUCREUX, M
    OLIVEIRA, J
    YCHOU, M
    PIGNON, JP
    ELIAS, D
    BELLEFQIH, S
    BOGNEL, C
    LUSINCHI, A
    CVITKOVIC, E
    DROZ, JP
    EUROPEAN JOURNAL OF CANCER, 1994, 30A (09) : 1269 - 1275
  • [6] PHASE-II TRIAL OF 5-FLUOROURACIL, ADRIAMYCIN AND CISPLATIN (FAP) FOLLOWED BY RADIATION AND 5-FLUOROURACIL IN LOCALLY ADVANCED PANCREATIC-CANCER
    WAGENER, DJT
    VANHOESEL, QGCM
    YAP, SH
    HOOGENRAAD, WJ
    WOBBES, T
    STRIJK, SP
    CANCER CHEMOTHERAPY AND PHARMACOLOGY, 1989, 25 (02) : 131 - 134
  • [7] A PHASE-II TRIAL OF 5-FLUOROURACIL AND HIGH-DOSE INTRAVENOUS LEUCOVORIN IN GASTRIC-CARCINOMA
    ARBUCK, SG
    DOUGLASS, HO
    TRAVE, F
    MILLIRON, S
    BARONI, M
    NAVA, H
    EMRICH, LJ
    RUSTUM, YM
    JOURNAL OF CLINICAL ONCOLOGY, 1987, 5 (08) : 1150 - 1156
  • [8] A phase II study of weekly high-dose 5-fluorouracil and leucovorin plus biweekly alternating doxorubicin and cisplatin for advanced gastric carcinoma
    M. Raida
    R. Kath
    M. Arnrich
    G. Kähler
    J. Scheele
    K. Höffken
    Journal of Cancer Research and Clinical Oncology, 1998, 124 : 335 - 340
  • [9] A PHASE-II STUDY OF COMBINED 5-FLUOROURACIL, DOXORUBICIN, AND CISPLATIN IN THE TREATMENT OF ADVANCED UPPER GASTROINTESTINAL ADENOCARCINOMAS
    MOERTEL, CG
    RUBIN, J
    OCONNELL, MJ
    SCHUTT, AJ
    WIEAND, HS
    JOURNAL OF CLINICAL ONCOLOGY, 1986, 4 (07) : 1053 - 1057
  • [10] Phase II trial of doxorubicin, 5-fluorouracil, etoposide, and cisplatin in advanced or recurrent endometrial carcinoma
    Pierga, JY
    Dieras, V
    Beuzeboc, P
    Dorval, T
    Palangie, T
    Jouve, M
    Scholl, SM
    GarciaGiralt, E
    Pouillart, P
    GYNECOLOGIC ONCOLOGY, 1997, 66 (02) : 246 - 249
12345